PMID- 38388828 OWN - NLM STAT- Publisher LR - 20240222 IS - 1179-1942 (Electronic) IS - 0114-5916 (Linking) DP - 2024 Feb 22 TI - Detection Algorithms for Simple Two-Group Comparisons Using Spontaneous Reporting Systems. LID - 10.1007/s40264-024-01404-w [doi] AB - Medical science has often used adult males as the standard to establish pathological conditions, their transitions, diagnostic methods, and treatment methods. However, it has recently become clear that sex differences exist in how risk factors contribute to the same disease, and these differences also exist in the efficacy of the same drug. Furthermore, the elderly and children have lower metabolic functions than adult males, and the results of clinical trials on adult males cannot be directly applied to these patients. Spontaneous reporting systems have become an important source of information for safety assessment, thereby reflecting drugs' actual use in specific populations and clinical settings. However, spontaneous reporting systems only register drug-related adverse events (AEs); thus, they cannot accurately capture the total number of patients using these drugs. Therefore, although various algorithms have been developed to exploit disproportionality and search for AE signals, there is no systematic literature on how to detect AE signals specific to the elderly and children or sex-specific signals. This review describes signal detection using data mining, considering traditional methods and the latest knowledge, and their limitations. CI - (c) 2024. The Author(s), under exclusive licence to Springer Nature Switzerland AG. FAU - Noguchi, Yoshihiro AU - Noguchi Y AUID- ORCID: 0000-0002-9110-9604 AD - Laboratory of Clinical Pharmacy, Gifu Pharmaceutical University, 1-25-4, Daigakunishi, Gifu, 501-1196, Japan. noguchiy@gifu-pu.ac.jp. FAU - Yoshimura, Tomoaki AU - Yoshimura T AD - Laboratory of Clinical Pharmacy, Gifu Pharmaceutical University, 1-25-4, Daigakunishi, Gifu, 501-1196, Japan. LA - eng GR - 22K12890/JSPS KAKENHI/ PT - Journal Article PT - Review DEP - 20240222 PL - New Zealand TA - Drug Saf JT - Drug safety JID - 9002928 SB - IM EDAT- 2024/02/23 00:42 MHDA- 2024/02/23 00:42 CRDT- 2024/02/22 23:56 PHST- 2024/02/04 00:00 [accepted] PHST- 2024/02/23 00:42 [medline] PHST- 2024/02/23 00:42 [pubmed] PHST- 2024/02/22 23:56 [entrez] AID - 10.1007/s40264-024-01404-w [pii] AID - 10.1007/s40264-024-01404-w [doi] PST - aheadofprint SO - Drug Saf. 2024 Feb 22. doi: 10.1007/s40264-024-01404-w.